Table 2.
No. of patients in component trials | P value | ||
---|---|---|---|
Large trials (>100 per arm, n = 73) | Small trials (<100 per arm, n = 244) | ||
Sequence generating | 0.031 | ||
Adequate | 29 (59%) | 50 (41%) | |
Inadequate/unclear | 20 (41%) | 72 (59%) | |
Allocation concealment | <0.001 | ||
Adequate | 56 (82%) | 114 (51%) | |
Inadequate/unclear | 12 (18%) | 111 (49%) | |
Blinding | <0.001 | ||
Adequate | 49 (67%) | 99 (41%) | |
Inadequate/unclear | 24 (33%) | 145 (59%) | |
Incomplete follow-up data addressed | <0.001 | ||
Adequate | 36 (86%) | 56 (48%) | |
Inadequate/unclear | 6 (14%) | 61 (52%) | |
Intention to treat | <0.001 | ||
Yes | 38 (83%) | 79 (52%) | |
No/unclear | 8 (17%) | 72 (48%) | |
Sample size calculation | <0.001 | ||
Yes | 29 (88%) | 32 (44%) | |
No/unclear | 4 (12%) | 40 (56%) | |
Year of publication | <0.001 | ||
Before 2002 | 55 (75%) | 127 (52%) | |
After 2002 | 18 (25%) | 117 (48%) |